Cargando…

The role of Nrf2 in astragaloside IV-mediated antioxidative protection on heart failure

CONTEXT: Heart failure is one of the most serious diseases worldwide. Astragaloside IV (ASI) is widely used in the treatment of cardiovascular diseases. OBJECTIVE: To elucidate the antioxidative mechanism of ASI in a rat model of left coronary artery ligation. MATERIALS AND METHODS: Left coronary ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sui, Yan-Bo, Zhang, Kui-Kui, Ren, Yu-kun, Liu, Li, Liu, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717863/ https://www.ncbi.nlm.nih.gov/pubmed/33253607 http://dx.doi.org/10.1080/13880209.2020.1849319

Ejemplares similares

Astragaloside IV alleviates heart failure by modulating Nrf-2
por: Feng, Wenxiao, et al.
Publicado: (2022)

Astragaloside IV alleviates heart failure by promoting angiogenesis through the JAK-STAT3 pathway
por: Sui, Yan-Bo, et al.
Publicado: (2019)

Effects of Astragaloside IV on heart failure in rats
por: Zhao, Zhuanyou, et al.
Publicado: (2009)

Review on the protective mechanism of astragaloside IV against cardiovascular diseases
por: Yang, Chunkun, et al.
Publicado: (2023)

Astragaloside IV alleviates heart failure by regulating SUMO-specific protease 1
por: Liu, Juan, et al.
Publicado: (2021)

[Corrigendum] Astragaloside IV alleviates heart failure by regulating SUMO‑specific protease 1
por: Liu, Juan, et al.
Publicado: (2023)

Protective Effects of Astragaloside IV Combined with Budesonide in Bronchitis in Rats by Regulation of Nrf2/Keap1 Pathway
por: Zhang, Zhijie, et al.
Publicado: (2018)

Protective Effects of Astragaloside IV on db/db Mice with Diabetic Retinopathy
por: Ding, Yuzhi, et al.
Publicado: (2014)

Astragaloside IV protects RGC-5 cells against oxidative stress
por: Hao, Ming, et al.
Publicado: (2018)

Protective Effect of Astragaloside IV on Hepatic Injury Induced by Iron Overload
por: Xie, Dongyu, et al.
Publicado: (2019)

Anticancer effects and mechanisms of astragaloside-IV
por: Zhou, Liangxing, et al.
Publicado: (2022)

Effects of astragaloside IV on the pharmacokinetics of omeprazole in rats
por: Liu, Wei, et al.
Publicado: (2019)

Astragaloside IV Attenuates Acetaminophen-Induced Liver Injuries in Mice by Activating the Nrf2 Signaling Pathway
por: Li, Lei, et al.
Publicado: (2018)

Roles and Mechanisms of Astragaloside IV in Combating Neuronal Aging
por: Zaman, Qumar, et al.
Publicado: (2022)

Astragaloside IV inhibits ventricular remodeling and improves fatty acid utilization in rats with chronic heart failure
por: Tang, Bin, et al.
Publicado: (2018)

Astragaloside IV attenuates ferroptosis after subarachnoid hemorrhage via Nrf2/HO-1 signaling pathway
por: Liu, Zhuanghua, et al.
Publicado: (2022)

Astragaloside IV attenuates lipopolysaccharide induced liver injury by modulating Nrf2-mediated oxidative stress and NLRP3-mediated inflammation
por: Sun, Yuxia, et al.
Publicado: (2023)

Pharmacological Effects of Astragaloside IV: A Review
por: Liang, Yutong, et al.
Publicado: (2023)

Astragaloside IV Alleviates Tacrolimus-Induced Chronic Nephrotoxicity via p62-Keap1-Nrf2 Pathway
por: Gao, Ping, et al.
Publicado: (2021)

Astragaloside IV Alleviates Cerebral Ischemia-Reperfusion Injury through NLRP3 Inflammasome-Mediated Pyroptosis Inhibition via Activating Nrf2
por: Xiao, Lan, et al.
Publicado: (2021)

Astragaloside IV inhibits pathological functions of gastric cancer-associated fibroblasts
por: Wang, Zhen-Fei, et al.
Publicado: (2017)

Astragaloside IV protects against apoptosis in human degenerative chondrocytes through autophagy activation
por: Liu, Jianhong, et al.
Publicado: (2017)

Astragaloside IV, a Novel Antioxidant, Prevents Glucose-Induced Podocyte Apoptosis In Vitro and In Vivo
por: Gui, Dingkun, et al.
Publicado: (2012)

Astragaloside IV protects retinal pigment epithelial cells from apoptosis by upregulating miR-128 expression in diabetic rats
por: Wang, Tao, et al.
Publicado: (2020)

Astragaloside IV protects against ischemia/reperfusion (I/R)-induced kidney injury based on the Keap1-Nrf2/ARE signaling pathway
por: Su, Yanyan, et al.
Publicado: (2022)

Research progress on the mechanism of astragaloside IV in the treatment of asthma
por: Yuan, Fanyi, et al.
Publicado: (2023)

Astragaloside IV, as a potential anticancer agent
por: Xia, Dongqin, et al.
Publicado: (2023)

Astragalosidic Acid: A New Water-Soluble Derivative of Astragaloside IV Prepared Using Remarkably Simple TEMPO-Mediated Oxidation
por: Qing, Lin-Sen, et al.
Publicado: (2017)

Astragaloside IV alleviates heart failure via activating PPARα to switch glycolysis to fatty acid β-oxidation
por: Dong, Zhiwei, et al.
Publicado: (2017)

Effect of Astragaloside IV on improving cardiac function in rats with heart failure: a preclinical systematic review and meta-analysis
por: Zhang, Zhiyuan, et al.
Publicado: (2023)

Astragaloside IV inhibits astrocyte senescence: implication in Parkinson’s disease
por: Xia, Mei-Ling, et al.
Publicado: (2020)

Astragaloside IV alleviates 1-deoxysphinganine-induced mitochondrial dysfunction during the progression of chronic kidney disease through p62-Nrf2 antioxidant pathway
por: Gui, Ting, et al.
Publicado: (2023)

Pharmacokinetic study on the co-administration of abemaciclib and astragaloside IV in rats
por: Sun, Sen, et al.
Publicado: (2022)

Astragaloside IV Inhibits the Proliferation of Human Uterine Leiomyomas by Targeting IDO1
por: Qiu, Tiantian, et al.
Publicado: (2022)

Astragaloside IV inhibits microglia activation via glucocorticoid receptor mediated signaling pathway
por: Liu, Hong-Shuai, et al.
Publicado: (2016)

Astragaloside IV derivative HHQ16 ameliorates infarction-induced hypertrophy and heart failure through degradation of lncRNA4012/9456
por: Wan, Jingjing, et al.
Publicado: (2023)

Protective effect of Astragaloside IV against sepsis-induced acute lung injury in rats
por: Huang, Ruiqin, et al.
Publicado: (2016)

Transcriptomic Analysis Reveals the Protection of Astragaloside IV against Diabetic Nephropathy by Modulating Inflammation
por: Zhang, Yudi, et al.
Publicado: (2020)

Research Progress on the Ability of Astragaloside IV to Protect the Brain Against Ischemia-Reperfusion Injury
por: Kang, Xianhui, et al.
Publicado: (2021)

Protective effect of Astragalus membranaceus and Astragaloside IV in sepsis-induced acute kidney injury
por: Tang, Jia-Long, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h3oec0982me97a8i05nvgds5i4